Gland Pharma Ltd.
GLAND Share PricePharmaceuticals & Drugs
₹1,734.9
-36.1 (-2%)
As on December 4, 2025
Exchange Scrips: BSE543245NSEGLANDISININE068V01023
Market Cap ₹ 28,503 Cr
P/E Ratio 40.92
Dividend Yield 1.04 %
Performance
Market performance
Open1,771
High1,771
Volumes1,33,475
Prev1,734.9
Low1,715.5
As on2025-12-04
Historical performance
1 Year High2,131
3 Year High2,220.95
5 Year High4,350
1 Year Low1,277.8
3 Year Low861
5 Year Low861
Fundamentals
Company Valuation
Market Cap (₹Cr)
28,503
Face Value (₹)
1
P/E Ratio
40.92
Dividend Yield
1.04 %
Investment Returns
1 Year
-3.7%
3 Years
0.8%
5 Years
-20.4%
10 Years
N/A
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 1,751.8 | Bearish |
| 10-DMA | 1,771.28 | Bearish |
| 20-DMA | 1,799.88 | Bearish |
| 50-DMA | 1,885.27 | Bearish |
| 100-DMA | 1,923.4 | Bearish |
| 200-DMA | 1,751.72 | Bearish |
Shareholding Pattern
| Field | Sep-2025 | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 |
|---|---|---|---|---|---|
| Promoters | 5 | 5 | 5 | 5 | 5 |
| Foreign Investors | 5 | 5 | 5 | 5 | 5 |
| Domestic Investors | --- | --- | --- | --- | --- |
| Public Investors | 97146 | 110666 | 113783 | 121070 | 122353 |
| Government | 1 | 1 | 1 | 1 | --- |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 40.92.
- 3Y Stock Price CAGR of the stock is -0.3.
- The stock has a beta of 0.7.
- In the last financial year, the company had an EBITDA of ₹14825 Million.
- The company generated revenue of ₹56165 Million in the previous financial year.
Gland Pharma Ltd.
1734.9-36.1 (-2%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 945862
No. of Shares: 545 (Approx)
Performance:-5.4%
P/L: ₹-54138
Top Gainers
Peer Comparison
Get Your Portfolio Reviewed
